An investigational monoclonal antibody called bentracimab can safely and effectively reverse potentially catastrophic bleeding complications linked to ticagrelor, a common drug used to treat patients ...

A novel combination therapy offers better outcomes for patients with KRAS G12C metastatic colorectal cancer that have stopped ...

During a live event, Jack Khouri, MD, discussed options for patients with multiple myeloma after relapse and choices to ...

Exposing children with peanut allergy to proteins from the legume is an approved treatment to reduce the risk of allergic ...

Monoclonal antibody therapy is complicated by the potential for the human immune system to form antibodies to these drugs. Antibodies can be formed to the Fv and Fc regions or to murine epitopes.

Better diagnostics, more focused treatment, and deeper understanding of individualized symptoms could all take major steps ...

A team of scientists has uncovered the remarkable potential of a human antibody, mAb 3A6, in fighting Ebola virus infections.

Allergies happen when your immune system overreacts to things that are usually harmless to most people: dust mites, pet ...

Sanofi and Regeneron's Dupixent (dupilumab) has gained approval from the FDA for chronic spontaneous urticaria (CSU) ...

Seven oral presentations will unveil novel immunotherapy insights, including IBI363, at one of oncology’s biggest global ...